# Alumis: Biotechnology, San Francisco, United States

> Alumis: Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Source: https://millionrounds.com/startup/alumis (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Alumis

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Funding reported Last round: Series C

Biotechnology San Francisco, United States

Company summary

- **Founded:** 2021 5 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** $529M in dollars
- **Last round:** Series C Mar 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Alumis has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Alumis raised

Funding, as reported

Reported in all **$529M** in dollars

Rounds **3**

Last round **Series C**

Last round date **Mar 2024**

Investors listed **12**

SEC Form D **$240M sold, 4 filings, last Jul 2024**

## Founders and team

From Alumis's own website: 7 on the team.

- **Martin Babler** President and CEO, Chairman of the Board
- **Jack Danilkowicz** Chief Commercial Officer
- **John Schroer** Chief Financial Officer
- **Mark Bradley** Chief Development Officer
- **Roy Hardiman** Chief Business and Strategy Officer
- **Sanam Pangali** Chief Legal Officer and Corporate Secretary
- **Grace Halteh** SVP, Head of Quality and Regulatory

## On 3 portfolio pages

Investors who name them

- [OrbiMed](https://millionrounds.com/fund/orbimed)
- [Nextech Invest](https://millionrounds.com/fund/nextech-invest)
- [Westlake Village Biopartners](https://millionrounds.com/fund/westlake-biopartners)

Each firm lists Alumis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Alumis in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)